A retrospective claims review published in JMCP found that switching or discontinuing biologics in patients with psoriasis resulted in higher health care utilization and overall medical costs.
A retrospective claims review published in JMCP found that switching or discontinuing biologics in patients with psoriasis resulted in higher health care utilization and overall medical costs.
AMCP webinar that provided an overview of key updates to the Format, Version 4.0, including new guidance related to emerging special topic considerations such as biosimilars, specialty drugs, and companion diagnostic tests.